The 12 - week combination of SOF / DCV / RBV achieved a 100 % SVR4 rate in
cirrhotic patients without the additive effect of extension of the treatment to 24 weeks with or without RBV (95.7 % and 92.5 %, respectively), and this was also true in
experienced patients.